𝔖 Bobbio Scriptorium
✦   LIBER   ✦

310 Acquired resistance to HSP90 inhibitor and cancer progression

✍ Scribed by R.C.C. Chai; J.L. Vieusseux; C.H. Nguyen; B.J. Lang; M.M. Kouspou; J.T. Price

Book ID
119602993
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
42 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

BIIB021, a synthetic Hsp90 inhibitor, ha
BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance
✍ Hong Zhang; Laura Neely; Karen Lundgren; Yong-Ching Yang; Rachel Lough; Noel Tim πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 629 KB

## Abstract 17‐AAG, the first‐generation clinical Hsp90 inhibitor, exhibits promising antitumor activity in clinical studies, but is limited by poor solubility and hepatotoxicity. To pursue compounds with better biopharmaceutical properties, we have developed a series of fully synthetic orally bioa